IndexIQ Advisors’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$48K Buy
+376
New +$45.3K ﹤0.01% 1140
2021
Q1
Sell
-19,298
Closed -$2.89M 1338
2020
Q4
$2.89M Sell
19,298
-1
-0% -$141 0.11% 139
2020
Q3
$2.55M Sell
19,299
-99
-0.5% -$12.9K 0.1% 144
2020
Q2
$2.25M Sell
19,398
-1,298
-6% -$150K 0.1% 151
2020
Q1
$2.03M Sell
20,696
-12,997
-39% -$1.7M 0.09% 103
2019
Q4
$4.9M Buy
33,693
+7,285
+28% +$1.01M 0.18% 107
2019
Q3
$3.52M Sell
26,408
-9,039
-26% -$1.17M 0.13% 125
2019
Q2
$4.05M Sell
35,447
-631
-2% -$73.9K 0.12% 140
2019
Q1
$4.47M Buy
+36,078
New +$4.1M 0.13% 118

Other funds holding ZBH

IndexIQ Advisors's ZBH Position: Q1 2022 in Review

IndexIQ Advisors opened a new position in Zimmer Biomet (ZBH) in Q1 2022: 376 shares worth $48K. The stake represents ﹤0.01% of the portfolio and ranks #1140 among its holdings. This is a return to the name: IndexIQ Advisors previously reported a position in ZBH as recently as Q4 2020.

IndexIQ Advisors first reported a position in ZBH in Q1 2019 and has held it in 9 quarters since. The position peaked at $4.9M in Q4 2019. 977 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

  • IndexIQ Advisors held 376 shares of Zimmer Biomet worth $48K as of Q1 2022.
  • Zimmer Biomet was a new IndexIQ Advisors position in Q1 2022.
  • Zimmer Biomet made up ﹤0.01% of IndexIQ Advisors's portfolio in Q1 2022, its #1140 holding.
  • IndexIQ Advisors first reported a position in Zimmer Biomet in Q1 2019 and has held it in 9 quarters since.
  • IndexIQ Advisors's Zimmer Biomet position peaked at $4.9M in Q4 2019.
  • 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on IndexIQ Advisors's 13F filing for Q1 2022, filed 6 May 2022.